Nerve Block versus no block in patients having chronic breast pain

Role of pectoral nerve block-II versus conservative management in chronic non-cyclical mastalgia pain - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068252

Enrollment

Registered

2024-06-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M954- Acquired deformity of chest and rib

Interventions

Intervention1: Pectoral nerve block-II: pectoral nerve block-II with 0.2% of ropivacaine 10 ml with 4 mg dexamethasone Control Intervention1: no block: no block Control Intervention2: no pectoral nerv

Eligibility

Inclusion criteria

Inclusion criteria: Patients having BMI 18 to = 35 kg.m-2. Patients of American Society of Anesthesiologists ASA I and II. Patients complaining of chronic non-cyclical mastalgia (more than 3 months)

Exclusion criteria

Exclusion criteria: 1.Patient’s unwillingness to participate in the study 2. Patients with malignancies 3. Pregnancy and lactation 4. Patient allergic to the study drug 5. Patient not able to understand pain score

Design outcomes

Primary

Measure	Time frame
average pain score using brief pain inventory short form pain scaleTimepoint: one month of follow up	—

Secondary

Measure	Time frame
1.Brief pain inventory short form pain scale. 2.Visual analogue score 3.Number of times the application of diclofenac gel 4.Monthly reduction in dose of rescue analgesic 5.Patient satisfaction score a 6.Haemodynamics & adverse effect Timepoint: 1.Baseline, 1 week, 2 months & 3 months 2.baseline ,5 minutes,10 minutes,15 minutes,30 minutes,1 hour 3.Baseline, 1 week, 2 months & 3 months 4. 1 month,2 months,3 month 5.1 & 3 months 6.baseline,5 minutes,10 minutes,15 minutes,30 minutes,1 hour	—

Measure

Time frame

1.Brief pain inventory short form pain scale. 2.Visual analogue score 3.Number of times the application of diclofenac gel 4.Monthly reduction in dose of rescue analgesic 5.Patient satisfaction score a 6.Haemodynamics & adverse effect Timepoint: 1.Baseline, 1 week, 2 months & 3 months 2.baseline ,5 minutes,10 minutes,15 minutes,30 minutes,1 hour 3.Baseline, 1 week, 2 months & 3 months 4. 1 month,2 months,3 month 5.1 & 3 months 6.baseline,5 minutes,10 minutes,15 minutes,30 minutes,1 hour

—

Countries

India

Contacts

Public ContactMuskan Singla

Government medical college and hospital sector 32

vanitaahujameetings2020@gmail.com9646121649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026